Devonian Health Group Announces Notice of Allowance for a US Patent Application Covering Use of Thykamine™ for the Treatment of Cardiovascular Diseases.

Go back to Devonian Health Group Announces Notice of Allowance for a US Patent Application Covering Use of Thykamine™ for the Treatment of Cardiovascular Diseases.
GLBSH FTSE DEV CON (NYSE: GSD) Delayed: 30.07 --0 (-0%)
Previous Close $30.07    52 Week High $28.34 
Open $4.26    52 Week Low $21.57 
Day High $30.07    P/E N/A 
Day Low $30.07    EPS $0.00 
Volume